Header Logo

Connection

RICARDO PIGNATELLI to United States Food and Drug Administration

Back to Details
This is a "connection" page, showing publications RICARDO PIGNATELLI has written about United States Food and Drug Administration.
RICARDO PIGNATELLI
Connection Strength
0.106
United States Food and Drug Administration
  1. Results of the U.S. Food and Drug Administration continued access clinical trial of the GORE HELEX septal occluder for secundum atrial septal defect. JACC Cardiovasc Interv. 2014 Aug; 7(8):905-12.
    View in: PubMed
    Score: 0.106
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.